US Patent Issued to Shire Human Genetic Therapies on Oct. 7 for "Anti-Flt-1 antibodies for treating Duchenne muscular dystrophy" (Belgian, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,146, issued on Oct. 7, was assigned to Shire Human Genetic Therapies Inc. (Lexington, Mass.).

"Anti-Flt-1 antibodies for treating Duchenne muscular dystrophy" was invented by Dennis Keefe (Lexington, Mass.), Hans De Haard (Zwijnaarde, Belgium), Natalie De Jonge (Zwijnaarde, Belgium) and Sofie Gabriels (Zwijnaarde, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, among other things, anti-Flt-1 antibodies and methods for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffer...